(avxl) news: did you lose money on anavex life sciences corp. investment? contact johnson fistel regarding class action investigation

San diego, california--(newsfile corp. - may 6, 2022) - shareholder rights law firm johnson fistel, llp is investigating potential violations of federal securities laws by anavex life sciences corp. ("anavex life sciences" or "the company") (nasdaq: avxl).on february 1, 2022, anavex life sciences announced a phase 3 trial of anavex2-73 (blarcamesine) for rett syndrome met primary and secondary endpoints. following this news, a senior writer at statnews stated, "anavex changed the primary and secondary endpoints...
AVXL Ratings Summary
AVXL Quant Ranking